ALLE.NYSEAllegion PLC

Form 4: Allegion SVP & CFO Awarded Stock Options, RSUs

Sentiment:

Insider Transaction Report


Allegion plc's SVP and CFO, Michael J. Wagnes, was granted 2,460 restricted stock units and 9,329 stock options as part of his compensation.

Summary

  • Michael J. Wagnes, Senior Vice President and Chief Financial Officer of Allegion plc, reported the acquisition of equity securities.
  • On February 19, 2026, Mr. Wagnes was granted 2,460 Ordinary Shares in the form of Restricted Stock Units (RSUs) at a price of $0.
  • These RSUs will vest in equal annual installments on February 19, 2027, February 19, 2028, and February 19, 2029.
  • Following this transaction, Mr. Wagnes beneficially owns 32,642 Ordinary Shares.
  • Additionally, on February 19, 2026, Mr. Wagnes was granted 9,329 Stock Options (Right to Buy) with an exercise price of $162.665.
  • These stock options will also vest in equal annual installments on February 19, 2027, February 19, 2028, and February 19, 2029, and have an expiration date of February 19, 2036.
  • Following this transaction, Mr. Wagnes beneficially owns 9,329 derivative securities in the form of stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, representing a standard disclosure of executive equity compensation without indicating any significant positive or negative operational or financial developments for the company.

Positives

  • The equity grants align the interests of the SVP and CFO with long-term shareholder value through future vesting schedules.
  • The grant of restricted stock units and stock options is a standard component of executive compensation, designed to attract and retain key talent.

Negatives

  • The future vesting and exercise of these equity awards could lead to a minor dilution of existing shareholder equity.

Future Outlook

The grants of restricted stock units and stock options are structured with future vesting dates, indicating a long-term incentive and retention strategy for the SVP and CFO, aligning their future performance with the company's success over the next three years.

Industry Context

StockSavvy.ai notes that equity-based compensation, such as restricted stock units and stock options, is a prevalent practice across various industries, including manufacturing and security solutions, to incentivize executive performance and foster long-term commitment. This filing reflects a routine compensation event for a key executive.

Stakeholder Impact

  • Shareholders: Potential for minor future dilution upon vesting and exercise of equity awards, balanced by increased incentive alignment for a key executive.
  • Employees (SVP and CFO): Enhanced long-term compensation and incentive to drive company performance.

Next Steps

  • The granted Restricted Stock Units and Stock Options will vest in equal annual installments on February 19, 2027, February 19, 2028, and February 19, 2029.

Key Dates

DateDescription
02/19/2026Date of transaction for the acquisition of Restricted Stock Units and Stock Options.
02/23/2026Date the Statement of Changes in Beneficial Ownership (Form 4) was signed.
02/19/2027First annual installment vesting date for Restricted Stock Units and Stock Options.
02/19/2028Second annual installment vesting date for Restricted Stock Units and Stock Options.
02/19/2029Third annual installment vesting date for Restricted Stock Units and Stock Options.
02/19/2036Expiration date for the granted Stock Options.

Keywords

Allegion plc, ALLE, Form 4, Insider Transaction, Restricted Stock Units, RSUs, Stock Options, Executive Compensation, Equity Grant, Michael J. Wagnes

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.